Clinical Analysis of The Invasive Cervical Cancer Patients Treated by Radical Hysterectomy.
- Author:
Young Joon CHOI
1
;
Seon Kyung LEE
;
Myong Cheol LIM
;
Sang Gi SEO
;
Seung Bo KIM
Author Information
1. Department of Obstetrics and Gynecology, Kyunghee University College of Medicine, Seoul, Korea. caduceus4u@hanmail.net
- Publication Type:Original Article
- Keywords:
Cervical cancer;
Radical hysterectomy
- MeSH:
Adenocarcinoma;
Carcinoma, Adenosquamous;
Carcinoma, Squamous Cell;
Humans;
Hysterectomy*;
Lymph Node Excision;
Lymph Nodes;
Neoplasm Metastasis;
Recurrence;
Retrospective Studies;
Survival Rate;
Urinary Tract Infections;
Uterine Cervical Neoplasms*
- From:Korean Journal of Obstetrics and Gynecology
2005;48(1):88-99
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: This study was undertaken to analyze the demographic profile and clinicopathologic characteristics of the patients with invasive cervical cancer who had undergone radical hysterectomy. METHODS: Records of 285 patients with invasive cervical cancer who had undergone radical hysterectomy and pelvic lymph node dissection at Kyung Hee University Hospital from January 1986 to March 2001 were reviewed retrospectively. In this study, we analyzed the clinicopathologic characteristics such as age, FIGO stage, histologic type, nodal metastasis, treatment modalities, complications, recurrence rates, and the overall 5-year survival rates et al. by using univariate anaysis and Kaplan-Meier method. RESULTS AND CONCLUSION: Ages ranged from 28 to 78. The mean age was 50.6. The number of patients of 285 being in FIGO stage Ia was 34 (11.9%), Ib 146 (51.2%), IIa 78 (27.4%), IIb 27 (9.5%). In the distribution of histological type, the number of squamous cell carcinoma was 258 (90.5%), adenocarcinoma 20 (7.0%), adenosquamous carcinoma 7 (2.5%). LN involvement was present in 5.9% with stage Ia, 16.4% with Ib, 24.4% with IIa, 25.9% with IIb. Obturator LN was the most frequently involved among pelvic lymph node. Urinary tract infection was the most common complication after surgery, occupying 15.1%. 26 cases (9.1%) developed recurrence. The recurrence rate was 0% in stage Ia, 8.2% in stage Ib, 11.5% in stage IIa, 18.5% in stage IIb. The overall 5-year survival rate was 100% in stage Ia, 89.4% in stage Ib, 80.0% in stage IIa and 72.2% in stage IIb. FIGO stage, tumor mass size, resection margin, lymph node involvement had a statistical prognostic significance (P<0.01).
